Article
Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma
15 Mar 2022
Abstract excerpt
Hepatocellular carcinoma (HCC) is one of the most frequently encountered malignant tumor types and to improve its treatment, effective prognostic biomarkers are urgently required. Cell cycle dysregulation is a significant feature of cancer progression. The aim of the present study was to estimate the expression levels of forkhead box protein M1 (FOXM1) and polo‑like kinase 1 (PLK1), both of which have essential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
